Clinical Trial Update: The Effect of Carvedilol VS Endoscopic Therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal Bleeding [Phase 4]

View source ↗

Summary

This Phase 4 trial compares carvedilol to endoscopic therapy for primary prevention of high-risk esophageal and gastric variceal bleeding in patients with liver…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Variceal Bleeding
• Gastric Variceal Bleeding
• Liver Cirrhosis

Drugs mentioned

• CARVEDILOL (Carvedilol)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Liver Cirrhosis, Esophageal and Gastric Varices | Phase 4 | Status: UNKNOWN